Literature DB >> 15247190

Iron, anaemia, and inflammatory bowel diseases.

C Gasche1, M C E Lomer, I Cavill, G Weiss.   

Abstract

Iron deficiency anaemia is one of the most common disorders in the world. Also, one third of inflammatory bowel disease (IBD) patients suffer from recurrent anaemia. Anaemia has significant impact on the quality of life of affected patients. Chronic fatigue, a frequent IBD symptom itself, is commonly caused by anaemia and may debilitate patients as much as abdominal pain or diarrhoea. Common therapeutic targets are the mechanisms behind anaemia of chronic disease and iron deficiency. It is our experience that virtually all patients with IBD associated anaemia can be successfully treated with a combination of iron sucrose and erythropoietin, which then may positively affect the misled immune response in IBD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15247190      PMCID: PMC1774131          DOI: 10.1136/gut.2003.035758

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  104 in total

1.  Anemia in IBD: the overlooked villain.

Authors:  C Gasche
Journal:  Inflamm Bowel Dis       Date:  2000-05       Impact factor: 5.325

Review 2.  Progress in understanding the pathogenesis of the anemia of chronic disease.

Authors:  R T Means; S B Krantz
Journal:  Blood       Date:  1992-10-01       Impact factor: 22.113

3.  Self-reported food intolerance in chronic inflammatory bowel disease.

Authors:  M Ballegaard; A Bjergstrøm; S Brøndum; E Hylander; L Jensen; K Ladefoged
Journal:  Scand J Gastroenterol       Date:  1997-06       Impact factor: 2.423

4.  The diagnosis of iron deficiency in patients with Crohn's disease.

Authors:  J A Child; B Brozović; N H Dyer; D L Mollin; A M Dawson
Journal:  Gut       Date:  1973-08       Impact factor: 23.059

5.  Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial.

Authors:  C Gasché; C Dejaco; T Waldhoer; W Tillinger; W Reinisch; G F Fueger; A Gangl; H Lochs
Journal:  Ann Intern Med       Date:  1997-05-15       Impact factor: 25.391

6.  Iron absorption and serum ferritin in chronic inflammatory bowel disease.

Authors:  U Bartels; N S Pedersen; S Jarnum
Journal:  Scand J Gastroenterol       Date:  1978       Impact factor: 2.423

7.  Recombinant human erythropoietin for treatment of anemia of chronic disease in children with Crohn's disease.

Authors:  R Dohil; E Hassall; L D Wadsworth; D M Israel
Journal:  J Pediatr       Date:  1998-01       Impact factor: 4.406

8.  Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

Authors:  J Glaspy; R Bukowski; D Steinberg; C Taylor; S Tchekmedyian; S Vadhan-Raj
Journal:  J Clin Oncol       Date:  1997-03       Impact factor: 44.544

9.  Structure/histotoxicity relationship of parenteral iron preparations.

Authors:  P Geisser; M Baer; E Schaub
Journal:  Arzneimittelforschung       Date:  1992-12

10.  Interferon-gamma exerts its negative regulatory effect primarily on the earliest stages of murine erythroid progenitor cell development.

Authors:  C Q Wang; K B Udupa; D A Lipschitz
Journal:  J Cell Physiol       Date:  1995-01       Impact factor: 6.384

View more
  120 in total

Review 1.  Diagnosis and management of iron deficiency anemia in patients with IBD.

Authors:  Jürgen Stein; Franz Hartmann; Axel U Dignass
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10-05       Impact factor: 46.802

Review 2.  Extraintestinal manifestations in inflammatory bowel disease.

Authors:  Silvio Danese; Stefano Semeraro; Alfredo Papa; Italia Roberto; Franco Scaldaferri; Giuseppe Fedeli; Giovanni Gasbarrini; Antonio Gasbarrini
Journal:  World J Gastroenterol       Date:  2005-12-14       Impact factor: 5.742

3.  Pathogenesis and treatment of anemia in inflammatory bowel disease.

Authors:  Günter Weiss; Christoph Gasche
Journal:  Haematologica       Date:  2010-02       Impact factor: 9.941

4.  Endoscopic findings of gastrointestinal involvement in Chinese patients with Behcet's disease.

Authors:  Jun Zou; Yan Shen; Da-Nian Ji; Song-Bai Zheng; Jian-Long Guan
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 5.  [Iron deficiency, Fatigue and Restless-Legs-Syndrome].

Authors:  Bettina Wurzinger; Peter König
Journal:  Wien Med Wochenschr       Date:  2016-08-30

Review 6.  Stimulating erythropoiesis in inflammatory bowel disease associated anemia.

Authors:  Georgia Tsiolakidou; Ioannis-E Koutroubakis
Journal:  World J Gastroenterol       Date:  2007-09-28       Impact factor: 5.742

7.  Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease.

Authors:  Ioannis E Koutroubakis; Pantelis Oustamanolakis; Christos Karakoidas; Gerassimos J Mantzaris; Elias A Kouroumalis
Journal:  Dig Dis Sci       Date:  2009-10-16       Impact factor: 3.199

Review 8.  Use of agents stimulating erythropoiesis in digestive diseases.

Authors:  Rosario Moreno López; Beatriz Sicilia Aladrén; Fernando Gomollón García
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

Review 9.  Anemia and inflammatory bowel diseases.

Authors:  Fernando Gomollón; Javier P Gisbert
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

Review 10.  Evaluation and treatment of iron deficiency anemia: a gastroenterological perspective.

Authors:  Amy Zhu; Marc Kaneshiro; Jonathan D Kaunitz
Journal:  Dig Dis Sci       Date:  2010-01-27       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.